Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Manal F. Abdelmalek"'
Autor:
Manal F. Abdelmalek, Jeongeun Hyun, Steven R. Patierno, Rebecca Caffrey, Cynthia A. Moylan, Muthana Al Abo, Anna Mae Diehl, Xiyou Zhou, Seh-Hoon Oh, Arun J. Sanyal, Kun Xiang, Rajesh Kumar Dutta, Raquel Maeso-Díaz, Jennifer A. Freedman
Publikováno v:
J Hepatol
Background & Aims Non-alcoholic fatty liver disease (NAFLD), the hepatic correlate of the metabolic syndrome, is a major risk factor for hepatobiliary cancer (HBC). Although chronic inflammation is thought to be the root cause of all these diseases,
Autor:
Anna Mae Diehl, Ning-Ping Zhang, Ying Wang, Chen Yang, Xiuping Liu, Xue-Jing Liu, Wen‐Yue Dong, Chang Liu, Li Xie, Manal F. Abdelmalek, Jian Wu, Chenjian Gu, Kuo Du, Chen Niu
Publikováno v:
Liver Int
Background and aims Treatment of non-alcoholic steatohepatitis (NASH) is challenging, because suppressing fibrotic progression has not been achieved consistently by drug candidates currently in clinical trials. The aim of this study was to investigat
Autor:
De Lisa Fairweather, Sanda Win, Stefano Ballestri, Tin Aung Than, Amedeo Lonardo, Fabio Nascimbeni, Ayako Suzuki, Manal F. Abdelmalek
Publikováno v:
Hepatology
Despite tremendous research advancements in nonalcoholic fatty liver disease (NAFLD), our understanding of sex differences in NAFLD remains insufficient. This review summarizes the current knowledge on sex differences in NAFLD, identifies gaps, and d
Autor:
Danielle, Brandman, Marie, Boyle, Stuart, McPherson, Mark L, Van Natta, Arun J, Sanyal, Kris, Kowdley, Brent, Neuschwander-Tetri, Naga, Chalasani, Manal F, Abdelmalek, Norah A, Terrault, Art, McCullough, Ricki, Bettencourt, Cyrielle, Caussy, David E, Kleiner, Cynthia, Behling, James, Tonascia, Quentin M, Anstee, Rohit, Loomba
Publikováno v:
Aliment Pharmacol Ther
Alimentary Pharmacology and Therapeuthics
Alimentary Pharmacology and Therapeuthics, 2022, 55 (11), pp.1441-1451. ⟨10.1111/apt.16874⟩
Alimentary Pharmacology and Therapeuthics
Alimentary Pharmacology and Therapeuthics, 2022, 55 (11), pp.1441-1451. ⟨10.1111/apt.16874⟩
International audience; BACKGROUND AND AIMS: Patients with nonalcoholic fatty liver disease (NAFLD) cirrhosis benefit from referral to subspecialty care. While several clinical prediction rules exist to identify advanced fibrosis, the cutoff for excl
Autor:
Robert H. Eckel, Leon A. Adams, Christos S. Mantzoros, Kenneth Cusi, Stephen A. Harrison, Fasiha Kanwal, Eugene E. Wright, Vincent Wai-Sun Wong, Hashem B. El-Serag, Rohit Loomba, Elisabetta Bugianesi, Manal F. Abdelmalek, Lee M. Kaplan, Kim Pfotenhauer, Jay H. Shubrook
Publikováno v:
Gastroenterology, vol 161, iss 5
Gastroenterology
Gastroenterology
Find AGA's NASH Clinical Care Pathway Appfor iOS and Android mobile devices at nash.gastro.org. Scan this QR code to be taken directly to the website.Nonalcoholic fatty liver disease (NAFLD) is becoming increasingly common, currently affecting approx
Autor:
C. Stephen Djedjos, Raul Aguilar Schall, Zachary Goodman, B. Mccolgan, G. Mani Subramanian, Anna Mae Diehl, Nezam H. Afdhal, Andrew J. Muir, Jaime Bosch, Vlad Ratziu, Zobair M. Younossi, Manal F. Abdelmalek, Arun J. Sanyal, Stephen H. Caldwell, Mitchell L. Shiffman, Catherine Jia, John G. McHutchison, Stephen A. Harrison, Robert P. Myers
Publikováno v:
Hepatology
Progression of nonalcoholic steatohepatitis (NASH) is incompletely characterized. We analyzed data on longitudinal changes in liver histology, hepatic venous pressure gradient (HVPG), and serum markers of fibrosis in 475 patients with NASH with bridg
Autor:
Laura A. Wilson, James Tonascia, Jeanne M. Clark, Srinivasan Dasarathy, Brent A. Neuschwander-Tetri, David E. Kleiner, Manal F. Abdelmalek, Bilal Hameed, Oscar W. Cummings, Arun J. Sanyal, Rohit Loomba, Kris V. Kowdley, Samer Gawrieh, Edward Doo, Naga Chalasani
Publikováno v:
Am J Gastroenterol
OBJECTIVES Patients with nonalcoholic fatty liver disease (NAFLD) and normal aminotransferase levels may have advanced liver histology. We conducted a study to characterize the prevalence of and factors associated with advanced liver histology in pat
Autor:
Kris V. Kowdley, Mark L. Van Natta, Arun J. Sanyal, James Tonascia, Edward Doo, Raj Vuppalanchi, Mohammad S. Siddiqui, David E. Kleiner, Manal F. Abdelmalek, Rohit Loomba, Danielle Brandman, Erin Hallinan, Brent A. Neuschwander-Tetri, Srinivas Dasarathy, Naga Chalasani
Publikováno v:
Hepatology. 67:134-144
Vibration-controlled transient elastography estimates liver stiffness measurement (LSM) and controlled attenuation parameter (CAP), which are noninvasive assessments of hepatic fibrosis and steatosis, respectively. However, prior vibration-controlled
Autor:
Laura A. Wilson, Nathan M. Bass, Ayako Suzuki, Ryan M. Gill, Norah A. Terrault, Marcelle I. Cedars, Manal F. Abdelmalek, Monika Sarkar, Katherine P. Yates
Publikováno v:
Clin Gastroenterol Hepatol
BACKGROUND: Higher testosterone contributes to imaging-confirmed nonalcoholic fatty liver disease (NAFLD) in women, but whether testosterone influences their disease severity is unknown. METHODS: The association of free testosterone (free T) with non
Autor:
Reshma Shringarpure, Beatrice Ferguson, Brent A. Neuschwander-Tetri, Kris V. Kowdley, Rohit Loomba, Alexander Liberman, Arun J. Sanyal, Naga Chalasani, Norah A. Terrault, David Shapiro, Manal F. Abdelmalek, Lois Lee, Jianfen Chen, Arthur J. McCullough
Publikováno v:
Gastroenterology, vol 156, iss 1
Background & aimsNonalcoholic steatohepatitis (NASH) is a leading cause of liver transplantation, and many trials are underway to evaluate potential therapies. The farnesoid X receptor ligand obeticholic acid in the NASH treatment trial evaluated the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d18ec713126acb68c4a3666d57d25d50
https://escholarship.org/uc/item/19g5c7t3
https://escholarship.org/uc/item/19g5c7t3